Spectral Medical Inc. has seen a modest uptick in its stock price this week, reflecting ongoing developments in its clinical trials and regulatory progress.
On Wednesday, Spectral Medical Inc. (EDT.TO) closed at C$1.40, marking a 1.44% increase for the day and a 2.92% rise over the past week. The company has been in the spotlight due to recent corporate updates that may influence investor sentiment.
Advertisement
Spectral Med Inc
EDT.TO
EDT.TO
Spectral Med Inc
WealthAwesomeMarket cap
$381.62M
52W high
$1.76
52W low
$1.21
1W change
-3.70%
Beta
0.21
Analyst Price Targets
Based on analyst covering EDT
Wall Street analysts forecast EDT stock price to rise 142.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.15
+142.3% Upside
Current Price
C$1.30
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EDT's historical volatility
30-Day Vol
30.4%
Annualized
90-Day Vol
29.1%
Annualized
Trend (90d)
-25.1%
Annualized drift
90d Mean
C$1.19
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$1.26 | C$1.14 โ C$1.40 |
| 60 trading days | C$1.22 | C$1.06 โ C$1.42 |
| 90 trading days | C$1.19 | C$0.99 โ C$1.43 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should be aware of the company's ongoing developments, particularly regarding its regulatory efforts and clinical trials, which could impact future performance.
C$1.40 closing price reflects a steady increase amid ongoing regulatory efforts.
The stock has a 52-week range of C$0.81 โ C$1.76, indicating it is currently at 62% of its high, suggesting room for growth but also volatility.
Bull case
Analysts have set an average target of C$3.15 for the stock, indicating significant potential upside. This optimism is driven by positive trial results and progress toward FDA approval.
Bear case
There are concerns about the company's financial health, with a profit margin of 0.0% and a negative return on equity. These factors may deter risk-averse investors from buying in.
Recent Price Action
Advertisement
Spectral Medical Inc. (EDT.TO) has seen its stock price close at C$1.40, reflecting a 1.44% increase on the day and a cumulative gain of 2.92% over the past week. The stock has performed well over the past month, appreciating by 6.02%, and has a year-to-date increase of 2.17%. This price action suggests steady interest among investors amid the company's ongoing developments.
Company News and Catalysts
While there are no significant recent announcements from Spectral Medical, the company has been in the news regarding its ongoing clinical trials and regulatory submissions. Notably, the completion of the Tigris trial enrollment and the positive topline results have been highlighted in previous reports, providing a backdrop of optimism for investors. The submission of the Premarket Approval (PMA) application for PMX to the FDA is another critical milestone that could enhance the company's market position.
Technical Picture
From a technical standpoint, Spectral Medical's stock is currently trading above its 50-day moving average of C$1.37 by approximately 1.9% and its 200-day moving average, also at C$1.37, by about 2.4%. The stock's 52-week range of C$0.81 โ C$1.76 indicates that it is currently at 62% of its high, suggesting potential for further upside. The beta of 0.21 indicates lower volatility compared to the broader market, which may appeal to conservative investors. However, the current trading volume of 4,200 shares is significantly below the 20-day average volume of 45,812 shares, indicating a lack of liquidity.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
